End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.51 CNY | -1.96% |
|
+6.23% | +22.32% |
07-03 | Tranche Update on Xiamen Jihong Co., Ltd's Equity Buyback Plan announced on November 6, 2024. | CI |
07-03 | Xiamen Jihong's H1 Profit to Rise Up to 65%; Shares Up 1% | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 14.81 | 5.72 | 5.55 | 7.02 | 3.4 | |||||
Return on Total Capital | 19.06 | 7.53 | 7.24 | 9.25 | 4.64 | |||||
Return On Equity % | 35.82 | 11.34 | 8.47 | 14.93 | 8.16 | |||||
Return on Common Equity | 35.5 | 12.6 | 9.29 | 15.65 | 8.12 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 43 | 38.33 | 40.53 | 46.37 | 43.75 | |||||
SG&A Margin | 26.67 | 30.56 | 32.17 | 38.34 | 37.92 | |||||
EBITDA Margin % | 15.59 | 6.81 | 6.77 | 7.07 | 5.37 | |||||
EBITA Margin % | 14.37 | 5.13 | 5.17 | 5.78 | 3.57 | |||||
EBIT Margin % | 14.11 | 5.08 | 5.11 | 5.73 | 3.49 | |||||
Income From Continuing Operations Margin % | 13.08 | 4.03 | 3.19 | 4.96 | 3.34 | |||||
Net Income Margin % | 12.67 | 4.39 | 3.42 | 5.15 | 3.29 | |||||
Net Avail. For Common Margin % | 12.67 | 4.39 | 3.42 | 5.11 | 3.29 | |||||
Normalized Net Income Margin | 8.26 | 3 | 2.59 | 3.62 | 2.17 | |||||
Levered Free Cash Flow Margin | 2.85 | -0.97 | 2.57 | 6.71 | 2.6 | |||||
Unlevered Free Cash Flow Margin | 3.21 | -0.69 | 2.82 | 6.84 | 2.74 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.68 | 1.8 | 1.74 | 1.96 | 1.56 | |||||
Fixed Assets Turnover | 7.34 | 7.21 | 6.48 | 7.24 | 5.57 | |||||
Receivables Turnover (Average Receivables) | 9.27 | 11.22 | 11.71 | 13.69 | 10.42 | |||||
Inventory Turnover (Average Inventory) | 9.4 | 8.96 | 7.06 | 7.64 | 6.88 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.05 | 2.04 | 2.15 | 2.22 | 1.82 | |||||
Quick Ratio | 1.62 | 1.36 | 1.52 | 1.65 | 1.33 | |||||
Operating Cash Flow to Current Liabilities | 0.55 | 0.25 | 0.37 | 0.71 | 0.36 | |||||
Days Sales Outstanding (Average Receivables) | 39.48 | 32.53 | 31.17 | 26.66 | 35.11 | |||||
Days Outstanding Inventory (Average Inventory) | 38.94 | 40.73 | 51.7 | 47.77 | 53.19 | |||||
Average Days Payable Outstanding | 61.29 | 50.78 | 54.83 | 59.29 | 80.2 | |||||
Cash Conversion Cycle (Average Days) | 17.13 | 22.49 | 28.05 | 15.13 | 8.1 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 23.8 | 15.62 | 18.23 | 15 | 15.05 | |||||
Total Debt / Total Capital | 19.23 | 13.51 | 15.42 | 13.05 | 13.08 | |||||
LT Debt/Equity | 2.49 | 2.44 | 3.28 | 9.47 | 7.99 | |||||
Long-Term Debt / Total Capital | 2.01 | 2.11 | 2.77 | 8.23 | 6.95 | |||||
Total Liabilities / Total Assets | 37.04 | 34.92 | 34.09 | 35.51 | 36.96 | |||||
EBIT / Interest Expense | 24.52 | 11.33 | 12.7 | 28.61 | 15.74 | |||||
EBITDA / Interest Expense | 27.11 | 15.83 | 17.71 | 37.76 | 27.03 | |||||
(EBITDA - Capex) / Interest Expense | 19.99 | 6.15 | 11.31 | 22.66 | 15.91 | |||||
Total Debt / EBITDA | 0.61 | 0.81 | 1.02 | 0.69 | 1 | |||||
Net Debt / EBITDA | -0.79 | -1.24 | -1.55 | -1.58 | -1.5 | |||||
Total Debt / (EBITDA - Capex) | 0.83 | 2.09 | 1.59 | 1.14 | 1.71 | |||||
Net Debt / (EBITDA - Capex) | -1.08 | -3.19 | -2.43 | -2.63 | -2.55 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 46.56 | 17.4 | 3.83 | 24.53 | -17.41 | |||||
Gross Profit, 1 Yr. Growth % | 45.64 | 4.65 | 9.78 | 42.47 | -22.07 | |||||
EBITDA, 1 Yr. Growth % | 48.67 | -48.7 | 3.06 | 29.79 | -37.42 | |||||
EBITA, 1 Yr. Growth % | 55.32 | -58.1 | 4.42 | 38.99 | -49.07 | |||||
EBIT, 1 Yr. Growth % | 58.96 | -57.71 | 4.43 | 39.68 | -49.75 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 66.57 | -63.79 | -17.86 | 93.57 | -44.46 | |||||
Net Income, 1 Yr. Growth % | 71.25 | -59.32 | -19.05 | 87.57 | -47.28 | |||||
Normalized Net Income, 1 Yr. Growth % | 72.23 | -57.32 | -10.33 | 74.11 | -50.51 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 65.53 | -59.46 | -20 | 91.43 | -46.74 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.45 | -10.52 | 10.98 | 3.23 | 13.27 | |||||
Inventory, 1 Yr. Growth % | 18.99 | 45.23 | 14.6 | -5.7 | -1.8 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 11.39 | 26.63 | 7.01 | 15.36 | 0.67 | |||||
Total Assets, 1 Yr. Growth % | 15.23 | 4.72 | 10.12 | 10.62 | -2.33 | |||||
Tangible Book Value, 1 Yr. Growth % | 43.05 | 6.16 | 12.4 | 9.04 | -3.37 | |||||
Common Equity, 1 Yr. Growth % | 23.71 | 7.3 | 12.24 | 8.84 | -3.44 | |||||
Cash From Operations, 1 Yr. Growth % | 70.05 | -56.42 | 58.62 | 85.6 | -46.71 | |||||
Capital Expenditures, 1 Yr. Growth % | -14 | 24.48 | -38.43 | 46.26 | -32.74 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -238.06 | -131.07 | -378.64 | 225.1 | -66.9 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -291.53 | -120.08 | -532.37 | 201.67 | -65.8 | |||||
Dividend Per Share, 1 Yr. Growth % | 70.07 | - | - | 112.93 | -39.64 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 39.41 | 31.17 | 10.41 | 13.71 | 1.42 | |||||
Gross Profit, 2 Yr. CAGR % | 39.55 | 23.46 | 7.19 | 25.06 | 5.37 | |||||
EBITDA, 2 Yr. CAGR % | 49.02 | -12.67 | -27.24 | 15.79 | -9.8 | |||||
EBITA, 2 Yr. CAGR % | 54.55 | -19.33 | -33.8 | 20.65 | -15.78 | |||||
EBIT, 2 Yr. CAGR % | 53.6 | -18.01 | -33.54 | 20.78 | -16.22 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 58.94 | -22.33 | -45.46 | 26.09 | 3.68 | |||||
Net Income, 2 Yr. CAGR % | 61.89 | -16.54 | -42.62 | 23.22 | -0.56 | |||||
Normalized Net Income, 2 Yr. CAGR % | 60.11 | -14.31 | -38.14 | 24.95 | -7.17 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 52.63 | -18.08 | -43.05 | 23.75 | 1.04 | |||||
Accounts Receivable, 2 Yr. CAGR % | 17.58 | -3.33 | -0.35 | 7.04 | 8.14 | |||||
Inventory, 2 Yr. CAGR % | 18.7 | 31.45 | 29.01 | 3.95 | -3.77 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 30.11 | 18.76 | 16.4 | 11.11 | 7.77 | |||||
Total Assets, 2 Yr. CAGR % | 33.02 | 9.85 | 7.4 | 10.37 | 3.94 | |||||
Tangible Book Value, 2 Yr. CAGR % | 91.13 | 23.23 | 9.21 | 10.7 | 2.65 | |||||
Common Equity, 2 Yr. CAGR % | 59.08 | 15.22 | 9.72 | 10.52 | 2.52 | |||||
Cash From Operations, 2 Yr. CAGR % | 44.87 | -13.91 | -16.86 | 75.7 | -0.55 | |||||
Capital Expenditures, 2 Yr. CAGR % | 116.03 | 3.47 | -12.46 | -5.1 | -0.82 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -19.51 | -25.85 | -7.35 | 200.97 | 2.02 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -18.44 | -30.66 | -7.38 | 261.16 | -0.07 | |||||
Dividend Per Share, 2 Yr. CAGR % | -38.05 | - | 62.17 | - | 13.37 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 57.32 | 31.65 | 21.34 | 14.93 | 2.21 | |||||
Gross Profit, 3 Yr. CAGR % | 78.57 | 26.78 | 18.72 | 17.85 | 6.82 | |||||
EBITDA, 3 Yr. CAGR % | 71.44 | 4.44 | -7.67 | -11.69 | -5.63 | |||||
EBITA, 3 Yr. CAGR % | 83.69 | 0.02 | -12.03 | -15.15 | -9.43 | |||||
EBIT, 3 Yr. CAGR % | 83.41 | -0.08 | -11.12 | -14.87 | -9.84 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 91.56 | -2.93 | -20.87 | -16.81 | -4.06 | |||||
Net Income, 3 Yr. CAGR % | 91.12 | 2.16 | -17.38 | -14.84 | -7.15 | |||||
Normalized Net Income, 3 Yr. CAGR % | 85.53 | 3.01 | -13 | -12.66 | -8.24 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 83.69 | -1.89 | -18.73 | -14.69 | -6.53 | |||||
Accounts Receivable, 3 Yr. CAGR % | 32.73 | 7.35 | 1.23 | 0.83 | 9.08 | |||||
Inventory, 3 Yr. CAGR % | 19.03 | 26.96 | 25.58 | 16.21 | 2 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 24.49 | 28.94 | 14.71 | 16.06 | 7.51 | |||||
Total Assets, 3 Yr. CAGR % | 34.77 | 22.83 | 9.95 | 8.46 | 5.96 | |||||
Tangible Book Value, 3 Yr. CAGR % | 53.87 | 57.11 | 19.49 | 9.15 | 5.8 | |||||
Common Equity, 3 Yr. CAGR % | 51.31 | 39.51 | 14.2 | 9.42 | 5.66 | |||||
Cash From Operations, 3 Yr. CAGR % | 104.59 | -2.93 | 5.54 | 10.39 | 18.05 | |||||
Capital Expenditures, 3 Yr. CAGR % | 41.47 | 79.76 | -12.97 | 3.88 | -15.39 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 33.38 | -36.34 | 14.95 | 40.78 | 42.6 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 46.43 | -44.93 | 27.11 | 37.29 | 62.83 | |||||
Dividend Per Share, 3 Yr. CAGR % | 30.5 | - | 64.76 | 77.58 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 53.24 | 55.48 | 36.54 | 24.16 | 12.94 | |||||
Gross Profit, 5 Yr. CAGR % | 77.49 | 77.54 | 45.59 | 26.09 | 13.19 | |||||
EBITDA, 5 Yr. CAGR % | 54.91 | 33.76 | 21.68 | 8.87 | -8.49 | |||||
EBITA, 5 Yr. CAGR % | 67.07 | 38.88 | 22.12 | 7.85 | -13.5 | |||||
EBIT, 5 Yr. CAGR % | 66.96 | 39.22 | 22.2 | 7.79 | -13.2 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 77.37 | 37.86 | 15.89 | 7.78 | -11.84 | |||||
Net Income, 5 Yr. CAGR % | 71.75 | 39.52 | 18.11 | 10.11 | -11.02 | |||||
Normalized Net Income, 5 Yr. CAGR % | 68.91 | 42.2 | 19.55 | 11.28 | -10.71 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 58.32 | 32.16 | 14.98 | 7.66 | -11.33 | |||||
Accounts Receivable, 5 Yr. CAGR % | 24.13 | 25.67 | 18.35 | 7.22 | 3.94 | |||||
Inventory, 5 Yr. CAGR % | 35.31 | 39.63 | 22.92 | 17.2 | 12.89 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.08 | 22.16 | 21.19 | 21.48 | 11.88 | |||||
Total Assets, 5 Yr. CAGR % | 35.61 | 31.37 | 23.07 | 17.69 | 7.51 | |||||
Tangible Book Value, 5 Yr. CAGR % | 50.08 | 35.23 | 34.15 | 36.57 | 12.44 | |||||
Common Equity, 5 Yr. CAGR % | 46.78 | 33.72 | 33.05 | 27.09 | 9.37 | |||||
Cash From Operations, 5 Yr. CAGR % | 57.72 | 97.14 | 42.71 | 23.07 | 4.04 | |||||
Capital Expenditures, 5 Yr. CAGR % | 39.51 | 25.69 | 16.76 | 39.23 | -8.3 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 27.57 | 51.49 | 21.15 | 18.3 | 9.59 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 26.02 | 24.33 | 27.48 | 16.56 | 15.45 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | 42.35 | 16.53 | 41.88 |
- Stock Market
- Equities
- 002803 Stock
- Financials Xiamen Jihong Co., Ltd
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition